Advanced search
Publication Cover
Expert Review of Endocrinology & Metabolism Volume 12, 2017 - Issue 4
Submit an article Journal homepage
219
Views
13
CrossRef citations to date
0
Altmetric
Review

Novel treatment options for anaplastic thyroid cancer

Poupak FallahiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
,
Ilaria RuffilliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
,
Giusy EliaDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
,
Francesca RagusaDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
,
Salvatore UlisseDepartment of Experimental Medicine, Sapienza University of Rome, Rome, ItalyView further author information
,
Enke BaldiniDepartment of Experimental Medicine, Sapienza University of Rome, Rome, ItalyView further author information
,
Mario MiccoliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
,
Gabriele MaterazziDepartment of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, ItalyView further author information
,
Alessandro AntonelliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyCorrespondence[email protected]
View further author information
&
Silvia Martina FerrariDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyView further author information
 show all
Pages 279-288 | Received 31 Jan 2017, Accepted 06 Jun 2017, Published online: 15 Jun 2017

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

MingLiang Ning, Shaojie Qin, Jia Tian, Yuchen Wang & Qingyuan Liu. (2021) LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway. Bioengineered 12:1, pages 1543-1554.
Read now
Diana P. Sousa, Marta Pojo, Ana T. Pinto, Valeriano Leite, Ana Teresa Serra & Branca M. Cavaco. (2020) Nobiletin Alone or in Combination with Cisplatin Decreases the Viability of Anaplastic Thyroid Cancer Cell Lines. Nutrition and Cancer 72:2, pages 352-363.
Read now

Articles from other publishers (11)

Chiara Liverani, Chiara Spadazzi, Toni Ibrahim, Federica Pieri, Flavia Foca, Chiara Calabrese, Alessandro De Vita, Giacomo Miserocchi, Claudia Cocchi, Silvia Vanni, Giorgio Ercolani, Davide Cavaliere, Nicoletta Ranallo, Elisa Chiadini, Giovanna Prisinzano, Stefano Severi, Maddalena Sansovini, Giovanni Martinelli, Alberto Bongiovanni & Laura Mercatali. (2023) HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors. Frontiers in Endocrinology 13.
Crossref
Camille Buffet, Lucie Allard, Erell Guillerm, Cécile Ghander, Elise Mathy, Charlotte Lussey-Lepoutre, Nicolas Julien, Eliane Touma, Pauline Quilhot, Gaelle Godiris-Petit, Jean-Marc Lacorte, Laurence Leenhardt & Jérôme Alexandre Denis. (2022) Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinoma. European Journal of Endocrinology 187:3, pages K33-K38.
Crossref
Enke Baldini, Dario Presutti, Pasqualino Favoriti, Simonetta Santini, Giuliana Papoff, Chiara Tuccilli, Raffaella Carletti, Cira Di Gioia, Eleonora Lori, Iulia Catalina Ferent, Federica Gagliardi, Antonio Catania, Daniele Pironi, Domenico Tripodi, Vito D’Andrea, Salvatore Sorrenti, Giovina Ruberti & Salvatore Ulisse. (2022) In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines. International Journal of Molecular Sciences 23:7, pages 3724.
Crossref
Yitian Li. (2021) Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer. BMC Complementary Medicine and Therapies 21:1.
Crossref
Salvatore Ulisse, Enke Baldini, Augusto Lauro, Daniele Pironi, Domenico Tripodi, Eleonora Lori, Iulia Catalina Ferent, Maria Ida Amabile, Antonio Catania, Filippo Maria Di Matteo, Flavio Forte, Alberto Santoro, Piergaspare Palumbo, Vito D’Andrea & Salvatore Sorrenti. (2021) Papillary Thyroid Cancer Prognosis: An Evolving Field. Cancers 13:21, pages 5567.
Crossref
Rukiye Arıkan, Tuğba Akın Telli, Nazım Can Demircan, Tuğba Başoğlu, Özlem Ercelep, Beste Melek Atasoy, Salih Özgüven, Faysal Dane & Perran Fulden Yumuk. (2021) Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature. Current Problems in Cancer 45:2, pages 100668.
Crossref
Jun-ya Han, Si Guo, Na Wei, Rui Xue, Wencai Li, Gang Dong, Jianhua Li, Xiangyu Tian, Chao Chen, Sen Qiu, Tong Wang, Qiankun Xiao, Chenguang Liu, Jingjing Xu & Kui-sheng Chen. (2020) ciRS-7 Promotes the Proliferation and Migration of Papillary Thyroid Cancer by Negatively Regulating the miR-7/Epidermal Growth Factor Receptor Axis. BioMed Research International 2020, pages 1-14.
Crossref
Diprajan Laha, Naris Nilubol & Myriem Boufraqech. (2020) New Therapies for Advanced Thyroid Cancer. Frontiers in Endocrinology 11.
Crossref
Jiangxia Zheng, Xian Cheng, Shichen Xu, Li Zhang, Jie Pan, Huixin Yu, Jiandong Bao & Rongrong Lu. (2019) Diallyl trisulfide induces G2/M cell-cycle arrest and apoptosis in anaplastic thyroid carcinoma 8505C cells. Food & Function 10:11, pages 7253-7261.
Crossref
Renjie Wang, Lina Zhao, Linlin Ji, Lin Bai & Qiang Wen. (2019) Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212. Biomedicine & Pharmacotherapy 118, pages 109298.
Crossref
Salvatore Ulisse, Chiara Tuccilli, Salvatore Sorrenti, Alessandro Antonelli, Poupak Fallahi, Eleonora D’Armiento, Antonio Catania, Francesco Tartaglia, Maria Amabile, Laura Giacomelli, Alessio Metere, Nicola Cornacchini, Daniele Pironi, Giovanni Carbotta, Massimo Vergine, Massimo Monti & Enke Baldini. (2019) PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications. International Journal of Molecular Sciences 20:6, pages 1405.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.